Skip to content
10-Q

Quarterly Report

Ernexa Therapeutics Inc. ERNA ERNAW

0001493152-25-021287

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 7.85M sh
Shares Diluted Q3 2025 · Sep 30, 2025 8.23M sh
Shares Diluted Q3 2025 · Sep 30, 2025 5.66M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 361K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 361K sh
Capex Q3 2025 · Sep 30, 2025 $22K
Capex Q3 2025 · Sep 30, 2024 $369K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$5.87M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$12.29M
Stockholders Equity Q3 2025 · Sep 30, 2025 $3.57M
Stockholders Equity Q3 2025 · Jun 30, 2025 $4.44M
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.7M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$45.39M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$8.53M
Stockholders Equity Q3 2025 · Dec 31, 2023 $2.23M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.14M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.94M
Total Liabilities Q3 2025 · Sep 30, 2025 $2.6M
Total Liabilities Q3 2025 · Dec 31, 2024 $3.57M
Current Assets Q3 2025 · Sep 30, 2025 $3.38M
Current Assets Q3 2025 · Dec 31, 2024 $2.35M
Total Assets Q3 2025 · Sep 30, 2025 $6.17M
Total Assets Q3 2025 · Dec 31, 2024 $5.27M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.15
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.23
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$73.70
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$107.45
Eps Basic Q3 2025 · Sep 30, 2025 −$0.15
Eps Basic Q3 2025 · Sep 30, 2025 −$2.23
Eps Basic restated Q3 2025 · Sep 30, 2024 −$73.70
Eps Basic restated Q3 2025 · Sep 30, 2024 −$107.45
Net Income Q3 2025 · Sep 30, 2025 −$1.24M
Net Income Q3 2025 · Sep 30, 2025 −$12.58M
Net Income Q3 2025 · Sep 30, 2024 −$26.6M
Net Income Q3 2025 · Sep 30, 2024 −$38.78M
Operating Income Q3 2025 · Sep 30, 2025 −$1.99M
Operating Income Q3 2025 · Sep 30, 2025 −$7.23M
Operating Income Q3 2025 · Sep 30, 2024 −$2.26M
Operating Income Q3 2025 · Sep 30, 2024 −$12.98M
Gross Profit Q3 2025 · Sep 30, 2024 $547K
Gross Profit Q3 2025 · Sep 30, 2024 $485K